A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects
Clinical trial NCT00002353 · COMPLETED
Trial details
- NCT number
- NCT00002353
- Sponsor
- United Biomedical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.